Biological Characteristics of Caspase-14 and Its Expression in Neoplastic Diseases in the View of Translational Medicine

doi:10.11910/2227-6394.2016.04.02. 06

Abstract
Figure/Table
References (31)
Related Citation (0)

Download: PDF (280 KB) RICH HTML
Export: BibTeX | EndNote (RIS)

Abstract

Caspase-14, a member of caspase family, only exists in mammals. As the most divergent member in the family of mammalian caspases, caspase-14 displays a variety of unique characteristics. It is expressed in a limited number of tissues and has the shortest amino acid sequence within the caspase protein family. At present, it has been found that caspase-14 is functionally different from the inflammatory reaction group of typical caspase family members. It exerts a certain effect in the promotion of final differentiation of epidermal cells and hydration of stratum corneum so as to maintain the steady state of skin barrier. In recent years, caspase-14 expression has been discovered in neoplastic diseases. Translational medicine integrates experimental research results and clinical guidance into the optimal implementation criteria for promoting the prediction, prevention and treatment of diseases. Via human genomics and molecular biology, translational medicine offers a possibility of screening molecular markers so that it can be used to diagnose the neoplastic diseases. In this article, the biological characteristics and substrates of caspase-14 as well as its expression in embryonic period and neoplastic diseases were reviewed.

Key words： Caspase-14 Neoplastic diseases Embryonic period Biological characteristics

Corresponding Authors: ZHONG Tian-ying, E-mail: tianyingzhong@163.com

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIU Kang-sheng
	LYU Juan
	LI Ping
	ZHONG Tian-ying

Cite this article:

LIU Kang-sheng,LYU Juan,LI Ping, et al. Biological Characteristics of Caspase-14 and Its Expression in Neoplastic Diseases in the View of Translational Medicine[J]. Journal of International Translational Medicine, 2016, 4(2): 109-113.

URL:

http://www.jitm.hk/EN/10.11910/2227-6394.2016.04.02. 06 OR http://www.jitm.hk/EN/Y2016/V4/I2/109

1. Saqi M, Pellet J, Roznovat I, et al. Systems medicine: The future of medical genomics, healthcare, and wellness. Methods Mol Biol. 2016, 1386: 43-60. doi: 10.1007/978-1-4939-3283-2_3.
2. Liu Q. Application of metabonomics in early diagnosis of diseases. J Int Transl Med, 2015, 3(2): 136-144. doi: 10.11910/2227-6394.2015.03.02.13.
3. Ryan BM, Faupel-Badger JM. The hallmarks of premalignant conditions: a molecular basis for cancer prevention. Semin Oncol, 2016, 43(1): 22-35. doi: 10.1053/j.seminoncol.2015.09.007.
4. Joehlin-Price AS, Elkins CT, Stephens JA, et al. Comprehensive evaluation of caspase-14 in vulvar neoplasia: an opportunity for treatment with black raspberry extract. Gynecol Oncol, 2014, 135(3): 503-509. doi: 10.1016/j.ygyno.2014.09.012.
5. Raymond AA, Méchin MC, Nachat R, et al. Nine procaspases are expressed in normal human epidermis, but only caspase-14 is fully processed. Br J Dermatol, 2007, 156(3): 420-427. doi: 10.1111/j.1365-2133.2006.07656.
6. Denecker G, Hoste E, Gilbert B, et al. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol, 2007, 9(6): 666-674. doi: 10.1038/ncb1597.
7. Hibino T, Fujita E, Tsuji Y, et al. Purification and characterization of active caspase-14 from human epidermis and development of the cleavage site-directed antibody. J Cell Biochem, 2010, 109(3): 487-497. doi: 10.1002/jcb.22425.
8. Yamamoto-Tanaka M, Hibino T. Caspase-14 protocols. Methods Mol Biol, 2014, 1133: 89-100. doi: 10.1007/978-1-4939-0357-3_5.
9. Gkegkes ID, Aroni K, Agrogiannis G, et al. Expression of caspase-14 and keratin-19 in the human epidermis and appendages during fetal skin development. Arch Dermatol Res, 2013, 305(5): 379-387. doi: 10.1007/s00403-013-1319-8.
10. Mikolajczyk J, Scott FL, Krajewski S, et al. Activation and substrate specificity of caspase-14. Biochemistry, 2004, 43(32): 10560-10569. doi: 10.1021/bi0498048.
11. Brocklehurst K, Philpott MP. Cysteine proteases: mode of action and role in epidermal differentiation. Cell Tissue Res, 2013, 351(2): 237-244. doi: 10.1007/s00441-013-1557-2.
12. Jiang YJ, Kim P, Uchida Y, et al. Ceramides stimulate caspase-14 expression in human keratinocytes. Exp Dermatol, 2013, 22(2): 113-118. doi: 10.1111/exd.12079.
13. Denecker G, Hoste E, Gilbert B, et al. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol, 2007, 9(6): 666-674. doi: 10.1038/ncb1597.
14. Yamamoto M, Miyai M, Matsumoto Y, et al. Kallikrein-related peptidase-7 regulates caspase-14 maturation during keratinocyte terminal differentiation by generating an intermediate form. J Biol Chem, 2012, 287(39): 32825-32834. doi: 10.1074/jbc.M112.357467.
15. Fischer H, Rossiter H, Ghannadan M, et al. Caspase-14 but not caspase-3 is processed during the development of fetal mouse epidermis. Differentiation, 2005, 73(8): 406-413. doi: 10.1111/j.1432-0436.2005.00046.
16. Chiang MH, Liang FY, Chen CP, et al. Mechanism of hypoxia-induced GCM1 degradation: implications for the pathogenesis of preeclampsia. J Biol Chem, 2009, 284(26): 17411-17419. doi: 10.1074/jbc.M109.016170.
17. Wu YH, Lo HF, Chen SH, et al. Caspase-14 suppresses GCM1 acetylation and inhibits placental cell differentiation. FASEB J, 2013, 27(7): 2818-2828. doi: 10.1096/fj.12-224279.
18. 18. White L, Dharmarajan A, Charles A. Caspase-14: a new player in cytotrophoblast differentiation. Reprod Biomed Online, 2007, 14(3): 300-307. doi:10.1016/S1472-6483(10)60871-1.
19. White LJ, Declercq W, Arfuso F, et al. Function of caspase-14 in trophoblast differentiation. Reprod Biol Endocrinol, 2009, 7: 98. doi: 10.1186/1477-7827-7-98.
20. Yoo NJ, Soung YH, Lee SH, et al. Mutational analysis of caspase-14 gene in common carcinomas. Pathology, 2007, 39(3): 330-333. doi: 10.1080/00313020701329815.
21. HY, Chen CY, Hung MF, et al. Caspase-14 is an anti-apoptotic protein targeting apoptosis-inducing factor in lung adenocarcinomas. Oncol Rep, 2011, 26(2): 359-369. doi: 10.3892/or.2011.1292.
22. Lemound J, Stucki-Koch A, Stoetzer M, et al. Aberrant expression of caspase-14 in salivary gland carcinomas. J Oral Pathol Med, 2015, 44(6): 444-448. doi: 10.1111/jop.12253.
23. Hoste E, Denecker G, Gilbert B, et al. Caspase-14-deficient mice are more prone to the development of parakeratosis. J Invest Dermatol, 2013, 133(3): 742-750. doi: 10.1038/jid.2012.350.
24. Jung M, Choi J, Lee SA, et al. Pyrrolidone carboxylic acid levels or caspase-14 expression in the corneocytes of lesional skin correlates withclinical severity, skin barrier function and lesional inflammation in atopic dermatitis. J Dermatol Sci, 2014, 76(3): 231-239. doi: 10.1016/j.jdermsci.2014.09.004.
25. Hvid M, Johansen C, Deleuran B, et al. Regulation of caspase 14 expression in keratinocytes by inflammatory cytokines--a possible link between reduced skin barrier function and inflammation? Exp Dermatol, 2011, 20(8): 633-636. doi: 10.1111/j.1600-0625.2011.01280.x.
26. Rundhaug JE, Hawkins KA, Pavone A, et al. SAGE profiling of UV-induced mouse skin squamous cell carcinomas, comparison with acute UV irradiation effects. Mol Carcinog, 2005, 42(1): 40-52. doi: 10.1002/mc.20064.
27. Wang X, Zhang J, Cheng Y, et al. Human caspase-14 expression in malignant melanoma and its significance. Chinese Journal of Cellular and Molecular Immonology, 2014, 30(11): 1180-1183. doi: 1007-8738(2014)11-1180-04.
28. Hsu S, Qin H, Dickinson D, et al. Expression of caspase-14 reduces tumorigenicity of skin cancer cells. In Vivo, 2007, 21(2): 279-283.
29. Krajewska M, Kim H, Shin E, et al. Tumor-associated alterations in caspase-14 expression in epithelial malignancies. Clin Cancer Res, 2005, 11(15): 5462-5471. doi: 10.1158/1078-0432.CCR-04-2527.
30. Scharenberg C, Eckardt A, Tiede C, et al. Expression of caspase 14 and filaggrin in oral squamous carcinoma. Head Neck Pathol, 2013, 7(4): 327-333. doi: 10.1007/s12105-013-0445-0.
31. Feng JF. Advances in targeted therapy of lymphoma. J Int Transl Med, 2015, 3(4): 292-297. doi: 10.11910/2227-6394.2015.03.04.12.